Does UPADACITINIB Cause Gait inability? 527 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 527 reports of Gait inability have been filed in association with UPADACITINIB (Rinvoq). This represents 0.8% of all adverse event reports for UPADACITINIB.
527
Reports of Gait inability with UPADACITINIB
0.8%
of all UPADACITINIB reports
86
Deaths
262
Hospitalizations
How Dangerous Is Gait inability From UPADACITINIB?
Of the 527 reports, 86 (16.3%) resulted in death, 262 (49.7%) required hospitalization, and 93 (17.6%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 527 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which UPADACITINIB Alternatives Have Lower Gait inability Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL